These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 19841897

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
    Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ, VANISH Investigators.
    JAMA; 2016 Aug 02; 316(5):509-18. PubMed ID: 27483065
    [Abstract] [Full Text] [Related]

  • 4. Beneficial effects of short-term vasopressin infusion during severe septic shock.
    Patel BM, Chittock DR, Russell JA, Walley KR.
    Anesthesiology; 2002 Mar 02; 96(3):576-82. PubMed ID: 11873030
    [Abstract] [Full Text] [Related]

  • 5. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD.
    Pharmacotherapy; 2004 Aug 02; 24(8):1002-12. PubMed ID: 15338849
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
    Russell JA, Lee T, Singer J, Boyd JH, Walley KR, Vasopressin and Septic Shock Trial (VASST) Group.
    Crit Care Med; 2017 Jun 02; 45(6):940-948. PubMed ID: 28333757
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
    Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, Bachetoni A, D'Alessandro M, Van Aken H, Pietropaoli P, Westphal M.
    Crit Care; 2009 Jun 02; 13(4):R130. PubMed ID: 19664253
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Low-dose vasopressin in the treatment of vasodilatory septic shock.
    Malay MB, Ashton RC, Landry DW, Townsend RN.
    J Trauma; 1999 Oct 02; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
    [Abstract] [Full Text] [Related]

  • 14. Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH).
    Gordon AC, Mason AJ, Perkins GD, Ashby D, Brett SJ.
    BMJ Open; 2014 Jul 03; 4(7):e005866. PubMed ID: 24993769
    [Abstract] [Full Text] [Related]

  • 15. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial.
    Liu ZM, Chen J, Kou Q, Lin Q, Huang X, Tang Z, Kang Y, Li K, Zhou L, Song Q, Sun T, Zhao L, Wang X, He X, Wang C, Wu B, Lin J, Yuan S, Gu Q, Qian K, Shi X, Feng Y, Lin A, He X, Study Group of investigators, Guan XD.
    Intensive Care Med; 2018 Nov 03; 44(11):1816-1825. PubMed ID: 29971593
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.
    Sacha GL, Lam SW, Wang L, Duggal A, Reddy AJ, Bauer SR.
    Crit Care Med; 2022 Apr 01; 50(4):614-623. PubMed ID: 34582425
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD, Jung R, Fish DN, MacLaren R.
    Ann Pharmacother; 2004 Apr 01; 38(7-8):1117-22. PubMed ID: 15178740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.